MGHL
Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
LONDON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that it will present at the...
Read moreDetails
Neurocrine Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SAN DIEGO , Jan. 6, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 43rd Annual J.P....
Read moreDetails
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
Saint Herblain (France), January 6, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces...
Read moreDetails
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th
Press Release – No. 1 / 2025 Zealand Pharma to present at the 43rd Annual J.P.
Read moreDetails
J.P. Morgan Asset Management Strengthens Retirement Business with Strategic Hires
Experienced Retirement Experts Josh Forstater and Tina Anstett Join the Firm NEW YORK , Jan. 6, 2025 /PRNewswire/ -- J.P....
Read moreDetails
Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced...
Read moreDetails
Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga. , Jan. 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive...
Read moreDetails
BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA
SAN RAFAEL, Calif. , Jan. 6, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President...
Read moreDetails
Recursion to Present at 43rd Annual JP Morgan Healthcare Conference
Salt Lake City, UT, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding...
Read moreDetails
Ascendis Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
COPENHAGEN, Denmark, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate...
Read moreDetails